236 related articles for article (PubMed ID: 16218478)
21. [OxLDL/β2-glycoprotein I complex as a pro-atherogenic autoantigen. Is atherosclerosis an autoimmune disease?].
Kraml P
Vnitr Lek; 2016; 62(11 Suppl 4):S48-51. PubMed ID: 27921425
[TBL] [Abstract][Full Text] [Related]
22. Atherogenic autoantigen: oxidized LDL complexes with beta2-glycoprotein I.
Matsuura E; Kobayashia K; Koikeb T; Shoenfeld Y; Khamashta MA; Hughes GR
Immunobiology; 2003; 207(1):17-22. PubMed ID: 12638898
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against beta2-glycoprotein I complexed with an oxidised lipoprotein relate to intima thickening of carotid arteries in primary antiphospholipid syndrome.
Ames PR; Delgado Alves J; Lopez LR; Gentile F; Margarita A; Pizzella L; Batuca J; Scenna G; Brancaccio V; Matsuura E
Clin Dev Immunol; 2006 Mar; 13(1):1-9. PubMed ID: 16603439
[TBL] [Abstract][Full Text] [Related]
24. Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus.
Nowak B; Szmyrka-Kaczmarek M; Durazińska A; Płaksej R; Borysewicz K; Korman L; Wiland P
Adv Clin Exp Med; 2012; 21(3):331-5. PubMed ID: 23214196
[TBL] [Abstract][Full Text] [Related]
25. The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation.
Matsuura E; Kobayashi K; Matsunami Y; Lopez LR
Autoimmun Rev; 2009 May; 8(6):500-5. PubMed ID: 19171205
[TBL] [Abstract][Full Text] [Related]
26. oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates.
Bassi N; Zampieri S; Ghirardello A; Tonon M; Zen M; Beggio S; Matsuura E; Doria A
Autoimmunity; 2009 May; 42(4):289-91. PubMed ID: 19811279
[TBL] [Abstract][Full Text] [Related]
27. Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome.
Matsuura E; Kobayashi K; Koike T; Shoenfeld Y; Khamashta MA; Hughes GR
Lupus; 2003; 12(7):550-4. PubMed ID: 12892397
[TBL] [Abstract][Full Text] [Related]
28. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome.
Kajiwara T; Yasuda T; Matsuura E
J Autoimmun; 2007; 29(2-3):164-73. PubMed ID: 17826950
[TBL] [Abstract][Full Text] [Related]
29. [Anti-beta2 glycoprotein I-beta2 glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases.
Biasiolo A; Rampazzo P; Brocco T; Barbero F; Rosato A; Pengo V
Lupus; 1999; 8(2):121-6. PubMed ID: 10192506
[TBL] [Abstract][Full Text] [Related]
30. Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?
Bećarevic M; Andrejević S; Bonaci-Nikolić B; Obradović I; Miljić P; Majkić-Singh N
Clin Lab; 2005; 51(5-6):279-83. PubMed ID: 15991801
[TBL] [Abstract][Full Text] [Related]
31. In vivo distribution of single chain variable fragment (scFv) against atherothrombotic oxidized LDL/β
Sasaki T; Kobayashi K; Kita S; Kojima K; Hirano H; Shen L; Takenaka F; Kumon H; Matsuura E
Autoimmun Rev; 2017 Feb; 16(2):159-167. PubMed ID: 27988435
[TBL] [Abstract][Full Text] [Related]
32. Intravenous immunoglobulin and atherosclerosis.
Matsuura E; Kobayashi K; Inoue K; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):311-9. PubMed ID: 16391407
[TBL] [Abstract][Full Text] [Related]
33. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
[TBL] [Abstract][Full Text] [Related]
34. Atherosclerosis, antiphospholipid syndrome, and antiphospholipid antibodies.
Nicolo D; Varadhachary AS; Monestier M
Front Biosci; 2007 Jan; 12():2171-82. PubMed ID: 17127454
[TBL] [Abstract][Full Text] [Related]
35. Oxidation of LDL and its clinical implication.
Matsuura E; Hughes GR; Khamashta MA
Autoimmun Rev; 2008 Jul; 7(7):558-66. PubMed ID: 18625445
[TBL] [Abstract][Full Text] [Related]
36. Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen.
Kobayashi K; Kishi M; Atsumi T; Bertolaccini ML; Makino H; Sakairi N; Yamamoto I; Yasuda T; Khamashta MA; Hughes GR; Koike T; Voelker DR; Matsuura E
J Lipid Res; 2003 Apr; 44(4):716-26. PubMed ID: 12562869
[TBL] [Abstract][Full Text] [Related]
37. A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages.
Kobayashi K; Matsuura E; Liu Q; Furukawa J; Kaihara K; Inagaki J; Atsumi T; Sakairi N; Yasuda T; Voelker DR; Koike T
J Lipid Res; 2001 May; 42(5):697-709. PubMed ID: 11352976
[TBL] [Abstract][Full Text] [Related]
38. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
[TBL] [Abstract][Full Text] [Related]
39. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
40. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease.
Rauch J; Salem D; Subang R; Kuwana M; Levine JS
Front Immunol; 2018; 9():2836. PubMed ID: 30619248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
